Pcas: Release of the 2021 Universal Registration Document (URD)
RELEASE OF THE 2021UNIVERSAL REGISTRATION DOCUMENT (URD)
Ecully,April29, 2022
The PCAS Universal Registration Document 2021, which includes the annual financial report, was filed with France's Financial Markets Authority, in ESEF format (European Single Electronic Format), on April 29, 2022, under number D.22-0386.
This document contains:
- The 2021 annual financial report
- The Board of Directors' corporate governance report in accordance with Section L.225-37 of France's Commercial Code
- Information on the statutory auditors' fees
This document is now available:
- At PCAS headquarters: 21 chemin de la Sauvegarde, 21 Ecully Parc, CS 33167, 69134 Ecully, France
- On the company website: www.pcas.com
| NEXT FINANCIAL DISCLOSURE: | |
| 2021Shareholder's Meetingin Ecully at
10a.m. on June9, 2022 |
ABOUT PCAS
PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With about 12% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €187.0 million in 2021 and employs nearly 1200 people in six countries.
To find out more about PCAS: www.pcas.com
| PCAS | Newcap |
| Philippe Clavel / Eric Moissenot |
Emmanuel Huynh / Louis-Victor Delouvrier Financial communication and investor relations |
| Tél. : +33 1 69 79 60 00 www.pcas.com |
Tél. : +33 1 44 71 98 53 [email protected] |
Attachment
- PCAS - REL_URD_2021
)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
